Meera J. Desai - 25 May 2023 Form 4 Insider Report for Adamis Pharmaceuticals Corp

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 25 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 May 2023, 18:15:16 UTC
Prior SEC filing: 06 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ David C. Benedicto, as Attorney-in-Fact

Filing notes and source

Key filing fact

Meera J. Desai filed Form 4 for Adamis Pharmaceuticals Corp on 30 May 2023.

Key facts

This page summarizes Meera J. Desai's Form 4 filing for Adamis Pharmaceuticals Corp.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 May 2023, 18:15.

Change

Previous filing in this sequence was filed on 06 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADMP transaction

Common Stock

Award

Transaction value
Shares: +3,138
Change %
Price
Shares after: 3,138
Date: 25 May 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On May 22, 2023, Adamis Pharmaceuticals Corporation ("Adamis") effected a 1 for 70 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Footnote F2

Received in exchange for common stock of DMK Pharmaceuticals Corporation, a privately held corporation ("DMK"), in connection with the merger of DMK into a subsidiary of Adamis (the "Merger"). On the effective date of the Merger, the closing price of Adamis common stock was $2.50 per share.